Search

everythinglearnresearchcommunity

for

Search:↓

miR-29a-5p prevents the formation of early hair structures by targeting a gene important for hair growth and is regulated by a complex network involving lncRNA627.1.

iPSCs could help develop treatments for hair loss.

New methods to test hair growth treatments have been developed.

Immune cells affect hair growth and could lead to new hair loss treatments.

Researchers created early-stage hair-like structures from skin cells, showing how these cells can self-organize, but more is needed for complete hair growth.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Adult skin cell-based early-stage skin substitutes improve wound healing and hair growth in mice.

Researchers created human hair follicles using a new method that could help treat hair loss.

Too much β-catenin activity can mess up the development of mammary glands and make them more like hair follicles.

A new method using a microfluidic device can prepare hair follicle germs efficiently for potential use in hair loss treatments.

New research shows that skin diversity is influenced by different types of dermal fibroblasts and their development, especially involving the Wnt/β-catenin pathway.

Keeping β-catenin levels high in mammary cells disrupts their development and branching.

Lactate production is important for activating hair growth stem cells.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Fully regenerating human hair follicles not yet achieved.

New hair follicles could be created to treat hair loss.

iPSCs show promise for hair regeneration but need more research to improve reliability and effectiveness.

The study concluded that the new wound model can be used to evaluate skin regeneration and nerve growth.

Type 1 Diabetes prevents hair growth by causing cell death in hair follicles.

The method can test hair growth products using a lab-made hair-like structure that responds to known treatments.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Scientists created early-stage hair follicles from human skin cells, which could help treat baldness and study hair growth.

Adding hyaluronic acid helps create larger artificial hair follicles in the lab.

Fat cells are important for tissue repair and stem cell support in various body parts.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.